Can someone explain this to me like 5? I feel dumb for not understanding but I don't and the only way I will is if I ask
Interestingly, I was working on exactly this for Monday's fact of the day so here's a little preview.
Kava, and more specifically kava extracts have been shown to inhibit the chemicals in our liver that break down pharmaceutical drugs. These chemicals are enzymes and they function to metabolize a very wide array of drugs and chemicals into their metabolites in the human liver. (
https://en.wikipedia.org/wiki/Cytochrome_P450)
When one or more of these enzymes are inhibited it reduces their ability to work on breaking down other chemicals.
There is thought and several papers have provided evidence that kava can inhibit CYP1A2, CYP2C9, CYP2C19, CYP2D6 (little, if any), and CYP3A4.
Alcohol, from what I'm seeing is broken down by CYP2E1 [1]. I'm not 100%, and it seems neither are these papers, but kava doesn't seem to hit this enzyme [1,2] in an inhibitory fashion. It may actually
induce activity at CYP2E1 [3]. There could be other down-process metabolites of ethanol that may interact with kava, but the science is still out in this arena. Yangonin doesn't seem to have been tested in these studies. DHM and Methysticin seem to be the most potent inhibitors in kava.
[1] Peter Guengerich, F, and Narayan G Avadhani. “Roles of Cytochrome P450 in Metabolism of Ethanol and Carcinogens.”
Advances in experimental medicine and biology vol. 1032 (2018): 15-35. doi:10.1007/978-3-319-98788-0_2
[2]Anke, J., & Ramzan, I. (2004).
Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). In Journal of Ethnopharmacology (Vol. 93, Issues 2–3, pp. 153–160).
https://doi.org/10.1016/j.jep.2004.04.009
[3] Tugcu, G., Kırmızıbekmez, H., & Aydın, A. (2020).
The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum. Food and Chemical Toxicology, 145.
https://doi.org/10.1016/j.fct.2020.111663